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Granulomatosis with polyangiitis (Wegener’s) (GPA) may mimic IgG4-related disease (IgG4-RD) on histologic examination of
some biopsies, especially those from head and neck sites. IgG4 immunostain is often performed in this context for diﬀerential
diagnosis with IgG4-RD. However, the prevalence of IgG4+ cells in GPA has not been explored. We examined the IgG4+ cells in
26 cases conﬁrmed as GPA by a thorough clinical and pathologic assessment. Twenty-six biopsies consisted of 14 sinonasal/oral
cavity/nasopharynx, 7 orbit/periorbital, 3 lung/pleura, 1 iliac fossa/kidney, and 1 dura specimens. Eight of 26 (31%) biopsies
revealed increased IgG4+ cells (>30/HPF and >40% in IgG4+/IgG+ ratio). The IgG4+ cells and IgG4+/IgG+ ratio ranged 37–
137/hpf and 44–83%, respectively. Eight biopsies with increased IgG4+ cells were from sinonasal (n = 4) or orbital/periorbital
(n = 4) sites. In conclusion, increased IgG4+ cells are not uncommonly seen in sinonasal or orbital/periorbital biopsies of GPA,
which could pose as a diagnostic pitfall.
1.Introduction
Granulomatosis with polyangiitis (Wegener’s) (GPA) is
an immune-mediated systemic necrotizing vasculitis often
aﬀecting the upper respiratory tract, lung, and kidney [1].
Involvement of GPA is limited to the upper respiratory tract
and/orthelunginsomecasesalthoughvirtuallyanybodysite
canbeinvolvedinGPAsuchastheeye,skin,joints,heart,and
the central nervous system [2]. Necrotizing vasculitis and
irregular basophilic parenchymal necrosis with associated
palisading granuloma comprise the main histologic charac-
teristics of GPA. Also, neutrophilic microabscesses and ﬁbro-
sis are commonly found in a background mixed inﬂamma-
toryinﬁltratecomposedofneutrophils,lymphocytes,plasma
cells, multinucleated giant cells, and macrophages [1, 2].
On histologic examination, GPA can mimic IgG4-related
disease (IgG4-RD) since the inﬂammatory background in
GPA may be rich in plasma cells and accompanied by ﬁbrosis
and/or obliterated blood vessels as in IgG4-RD [1, 3, 4].
SomebiopsiesofGPAcases(especiallyfromtheupperrespir-
atory tract and orbit) may lack classic morphologic features
such as necrotizing vasculitis, parenchymal necrosis, and
palisading granuloma [5, 6]. IgG4 immunostain is now often
performed in this context for evaluating the possibility of
IgG4-RD. However, the prevalence of IgG4-positive (IgG4+)
cells in GPA has not been widely reported in the literature.
Therefore, we sought to assess the prevalence of IgG4+ cells
in GPA cases that have been conﬁrmed by a thorough clinical
and pathologic assessment.
2.MaterialsandMethods
2.1. Case Selection. Cases with the diagnosis of GPA were
identiﬁed via electronic search from our surgical pathology
ﬁle. We initially retrieved 36 biopsies from various body
sites obtained during a period of 1999–2011. The sites of
biopsies included sinus/nasopharynx (n = 16), oral cavity
(n = 1), orbital region (n = 11), lung/pleural (n = 6),
kidney (n = 1), and dura (n = 1). Glass slides from
each biopsy were reviewed and reassessed for the following
histologic features: geographic necrosis, necrotizing granu-
lomas, vasculitis, multinucleated giant cells, microabscesses,2 International Journal of Rheumatology
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Figure 1: (a) Increased IgG4-positive cells with a high IgG4+/IgG+ ratio. (b) IgG+ cells from corresponding hotspot (immunohistochem-
istry, 400x original magniﬁcation).
and ﬁbrosis. Based on these histologic parameters, each case
was scored as to the conﬁdence of histopathologic diagnosis
o fG P Aa sf o l l o w s :0= nondiagnostic biopsy or not GPA with
some ﬁndings against the diagnosis of GPA such as infection,
1 = nonspeciﬁc (one feature present); 2 = suggestive of GPA
(two features present), or 3 = consistent with GPA (three
or more features present). A deﬁnitive clinicopathologic
diagnosis of GPA was made if a case had met the modiﬁed
clinical criteria of the American College of Rheumatology
(ACR) for GPA [7, 8] (modiﬁed to include assessment of
ANCA status) and a pathology diagnostic score of 1, 2, or
3. Twenty-six of the initial 36 cases were conﬁrmed as the
diagnosis of GPA and retained for this study.
2.2. Immunohistochemistry. Immunohistochemical staining
for IgG4 and IgG was performed on all 26 cases using the
DAKO dual multimer system or DAKO advance 2 stops mul-
timer system (DAKO, Carpinteria, CA, USA). Monoclonal
IgG4 antibody (clone HP6025, dilution 1:100; Zymed, San
Francisco, CA, USA) and polyclonal rabbit antihuman IgG
antibody (dilution 1:15,000, DAKO, Carpinteria, CA, USA)
were used for the study.
2.3. Quantitation. IgG4+ and IgG+ cells were counted using
the following steps.
(1) Areas of highest density of IgG4+ plasma cells “hot-
spot” were identiﬁed at low power magniﬁcation.
(2) Using40xobjectivelens(OlympusBX50microscope,
40x objective, 10x eye piece, Olympus DP70 camera,
on-screencaptureﬁelddiameterof0.34mmandﬁeld
area of 0.0884mm2), three high-power ﬁelds (HPFs)
of IgG4+ hot spots, and their corresponding areas of
IgG immunostain were photographed.
(3) All photographs were printed for a manual counting
of the absolute number of IgG4+ and IgG+ plasma
cells in each HPF.
(4) Averages of IgG4+ and IgG+ cells in three HPFs
were used to determine the IgG4+ cell count and
IgG4+/IgG+ ratio for each case. Increase in IgG4+
cells was deﬁned as the average IgG4+ cells greater
than 30 per HPF with the IgG4+/IgG+ cell ratio
greater than 40%.
2.4. Serum C-Reactive Protein and Immunoglobulin Levels.
Patients’ medical records from our institution were reviewed
fortheirserumlevelsofC-reactiveprotein(CRP)andimmu-
noglobulin subclasses.
3. Results
Eight of 26 biopsies (31%) showed increased IgG4+ cells
with an average IgG4+ cell count and an IgG4+/IgG+ cell
ratio ranging from 37 to 137/HPF and from 44 to 83%,
respectively (Figure 1). These 8 biopsies were from sinonasal
(n = 4) and orbital/periorbital (n = 4). The IgG4+
cell count ranged from 0 to 28/HPF in the remaining 18
biopsies that were from sinonasal/oral cavity/nasopharynx
(n = 10), orbit/periorbital (n = 3), lung/pleura (n = 3),
iliac fossa/kidney (n = 1), and dura (n = 1). The IgG4+ cell
counts and IgG4/IgG ratios in the cases without increase in
IgG4+ cells ranged from 0 to 28 per HPF and from 0 to 39%,
respectively (Table 1). There was no signiﬁcant diﬀerence
in the distribution of age at diagnosis or gender between
the cases with and without increased IgG4+ cells. Elevated
titers of antineutrophil cytoplasmic autoantibodies (ANCA)
were present in 25 of 26 cases in this study. All 8 cases with
increased IgG4+ cells were positive for ANCA; seven cases
were C-ANCA positive, 6 of which were also positive for
proteinase 3 (PR-3) ANCA by ELISA. One case was positive
for P-ANCA conﬁrmed as myeloperoxidase (MPO) ANCA
by ELISA. On histopathologic evaluation, most cases showed
characteristic histologic ﬁndings of GPA (Figure 2); 2 of 8
cases were graded as pathologic score 3, 2 as score 2, and the
remaining 4 as score 1. Details are summarized in Table 1.
The 26 biopsies in this study were obtained from 23
patients. The status of serum CRP level was assessed at the
time of the biopsy in 18 patients, and it was elevated in
15 of them (83%) (Table 1). Immunoglobulin levels were
evaluated in only three patients (case 7, 9, and 17) and did
not reveal polyclonal hypergammaglobulinemia. The serumInternational Journal of Rheumatology 3
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Figure 2: Parenchymal necrosis with palisading granuloma, necro-
tizing vasculitis, and mixed inﬂammatory inﬁltrates, characteristic
of GPA (hematoxylin and eosin, 100x original magniﬁcation).
IgA and IgG4 levels in these three patients were within
normal range. The eight biopsies with increased IgG4+ cells
were taken from seven patients, ﬁve of whom had elevated
CRP levels (Table 1). The two patients with normal CRP
levels demonstrated classic histopathologic features includ-
ing geographic necrosis, palisading granulomas, vasculitis,
or microabscesses, which supported the clinicopathologic
diagnosis of GPA despite the normal CRP level.
4. Discussion
In this study, we sought to determine the prevalence of
increased IgG4+ plasma cells in GPA in order to address the
role of this ﬁnding in the diﬀerential diagnosis with IgG4-
RD. We believe that this is the largest series of GPA cases
to examine IgG4+ cells with application of current criteria
and method for evaluation of increased IgG4+ cells in the
setting of IgG4-RD. An increase in IgG4+ cells in GPA has
been suggested in a recent study by Vaglio et al. [9]i nw h i c h
they reviewed tissue IgG4/IgG ratio in 10 GPA cases along
with 9 cases with the Churg-Strauss syndrome (CSS) and 22
cases with chronic sinusitis. However, they did not provide
the details on the counting method or results of IgG4+ cells.
In our study, we applied the current criteria and methods
in counting IgG4+ cells, which should provide useful and
importantinformationinroutine diagnostic surgicalpathol-
ogy practice. Also, we made an extra eﬀort to ensure the
diagnosis of GPA by a thorough clinicopathologic evaluation
and only included the cases with irrefutable diagnosis of
GPA. All but one case showed positivity for C- or P-ANCA
conﬁrmed with ELISA for PR3 or MPO; the single ANCA
negative case demonstrated deﬁnite histopathologic ﬁndings
(pathologic diagnosis score 3) as well as clinical features for
GPA, which supported our diagnosis of GPA. Moreover, all
8 cases with increased IgG4+ cells in this study were positive
for ANCA, which reiterated our point.
The cutoﬀ number of increased IgG4+ plasma cells has
not been well established, and many studies have suggested
diﬀerent cutoﬀ points. Kamisawa et al. and Zhang et al.
have used a cutoﬀ point of >30 per HPF [10, 11] (40x
objective lens) while Deshpande et al. and Dhall et al. used
>50HPF(20xor40xobjectives,resp.),andtheyhavereached
high sensitivity and speciﬁcity in diagnosing autoimmune
pancreatitis [12, 13]. In addition to this variable thresholds,
the method for counting IgG4+ cells has not been well
standardized. We used the same method as in our previous
study [14] by enumerating cells on printed images and using
averages of three “hot spots” in order to ensure accuracy
and reproducibility. We also applied a higher threshold for
increased IgG4+ cells by using both the IgG4+ cell count
per HPF at >30 and the ratio of IgG4+/IgG+ cells at >40%.
Cheuk et al. have proposed that both absolute number of
IgG4+ cell higher than 50 per HPF and IgG4+/IgG+ ratio
greater than 40% should be present in order to make the
diagnosis of IgG4-RD involving lymph nodes and other
extranodal sites [3]. Although our cutoﬀs for IgG4+ status
may be slightly lower than the histologic criteria proposed
by Cheuk et al. (which also used averages of three diﬀerent
HPFs), the latter used a wider ﬁeld area than the one in our
study (0.196mm2 versus 0.088mm2, resp.). Therefore, the
threshold used in this study would be comparable to the one
of the most stringent ones in the literature.
The most recent comprehensive diagnostic criteria for
IgG4-RD published by Umehara et al. included two major
components: (1) serum IgG4 concentration of >135mg/dL
and (2) >10 IgG4+ plasma cells/HPF with a ratio of
IgG4+/IgG+ cells >40% [15]. IgG4 serum level was not
increased in the 3 cases tested in our study. Instead, most of
our GPA cases showed elevated serum CRP which is unusual
for IgG4-RD. Based on their criterion for IgG4+ cell count as
>10, however, potentially additional ﬁve cases in our study
would have been considered to have suﬃciently increased
IgG4+ cells, which will make 50% of our GPA cases with
increased IgG4+ cells.
Positive ANCA has been reported in patients with
Grave’s disease receiving antithyroidal medication such as
propylthiouracil (PTU) [16, 17] and may even mimic GPA
clinically[18].However,noneofourpatientshadahistoryof
eitherGraves’sdiseaseortreatmentwithPTU.Thepossibility
of positive ANCA in patients with IgG4-RD has not been
addressedinpreviousstudies,andwhetherthiscanoccurhas
yet to be determined. A further study with testing for ANCA
in IgG4-RD would be needed to answer this question.
Previous studies have reported the presence of inﬂam-
matory inﬁltrates rich in IgG4+ plasma cells in clinical
settings other than IgG4-RD [19–21], usually as an isolated
ﬁnding. In kidneys, several studies have highlighted a
frequent association of IgG4+ plasma cell-rich inﬁltrates
with the glomerular lesions that are typically seen in ANCA-
associated angiitis, namely, pauci-immune necrotizing and
crescentic glomerulonephritis [19, 20]. In midst of all these
ﬁndings, questions regarding the nature of relationship
between IgG4+ plasma cells and GPA can arise. Interestingly,
there have been some data suggesting that ANCA of IgG4
subclass possibly plays a role in the pathogenesis of ANCA-
related small vessel vasculitis [22–24].
T h ep r e d o m i n a n c eo fI g G 4a sw e l la sI g G 1s u b c l a s s e so f
ANCA was ﬁrst reported in patients with GPA and other
clinically related disorders by Brouwer et al. in 1991 [22].
Holland et al. later suggested a possible pathogenic role forInternational Journal of Rheumatology 5
the IgG4 subclass in GPA [23]. In vitro,A N C Aa c t i v a t e d
neutrophils by colligating PR3 and FcγRIIa/IIIb receptors
[23]. ANCA are predominantly of the IgG isotype, and IgG1,
IgG3, and IgG4 subclasses are particularly represented. IgG4
subclass isolated from ANCA-positive sera demonstrated
varyingabilitiestostimulatereleaseofsuperoxide,whichwas
unrelated to PR3-ANCA titer, neutrophil donor used in their
in vitro test, or neutrophil FcγRI expression [23]. This study
suggested that IgG4 was capable of activating neutrophils
via constitutively expressed FcγRIIa/IIIb or colligation of
other unidentiﬁed cell surface molecules [23]. Liu et al. have
reported that MPO-ANCA IgG4 subclass might play a role
in the development of GPA [25]. They reported that the
titers of anti-MPO IgG4 subclass in patients with GPA was
signiﬁcantly higher than those with microscopic polyangiitis
(MPA). The MPO-ANCA in GPA and MPA might recognize
overlapping but diﬀerent epitopes on native MPO molecule.
The diﬀerence in immunological characteristics of MPO-
ANCA might have contributed to diﬀerent disease entities
such as GPA and MPA. Another recent study reported that
serum IgG4 levels were markedly elevated in active CSS and
also correlated with the disease activity and the number of
involved organs [9].
Given these serological and immunological ﬁndings, one
can postulate a possible role of tissue inﬁltrating IgG4+ cells
in the pathogenesis of GPA. However, the underlying cause
or precise mechanism for increased IgG4+ cells in the tissue
as seen in some of our GPA cases has not been completely
elucidated and further study would be needed in the future.
Also, whether there is any pathogenetic relationship between
GPA and IgG4-RD is not entirely clear. Although there
have been studies reporting elevated IgG4 in the setting of
ANCA-associated systemic diseases, no study demonstrating
elevated ANCA in IgG4-RD exists in the English literature to
our knowledge. Our anecdotal experiences also indicate that
the ANCA is generally not elevated in IgG4-RD.
In conclusion, one should be aware of the fact that
IgG4+ cells can be remarkably increased in biopsies of GPA
of the sinonasal and orbital/periorbital regions. Since the
morphologic and clinical manifestations of GPA and IgG4-
RD may overlap, it could be a signiﬁcant diagnostic pitfall in
the diﬀerential diagnosis of these two entities. Further study
is needed to conﬁrm our observation in a larger number of
cases, and a further exploration of potential pathogenetic
relationship between GPA and IgG4-RD might be of interest
as well.
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